//Lutfi Zylbeari
Lutfi Zylbeari 2018-10-12T09:53:37+00:00

Authors
Title
Journal
Number/Vol
Pages
Year
ISSN
Attachment
ZYLBEARI LUTFI, CAKALAROSKI K.EFFECT OF SIMVASTATIN ON TRYGLICERIDE,LOW -DENSITYAND HIGH DENSITY CHOLESTEROL KINETICS IN CHRONICAL HAEMODILAYSIS PATIENTSMEDICUS 229-3420041409/6366
LUTFI ZYLBEARIKORIGJIMI I HERSHEM I ANEMISE TEK PACIENTET ME INSUFICIENCER RENALE KRONIKE TERMINALE MEDICUSVO.284-871409-6366
ZYLBEARI LUTFIEFEKTITE NA SIMVASTATINOT VRZ LIPIDNIOT PROFIL KAJ PACIENTI NA HRONICNA HEMODIALIZAVOX MEDICIN 4514-17200414098865
ZYLBEARI LUTFILIPID PROFILE OF PATIENTS WITH TERMINAL CHRONIC RENAL INSUFFICIENCY TREATED WITH REPEATED HEMODIALYSISBANTAOVOL.38-112005
LUTFI ZYLBEARIPROFILI I LIPIDEVE TE PACIENTET ME ISUFICIENC KORONARE MEDICUS21-5200514096366
LUTFI ZYLBEARILIPID PROFIL OF PATIENT WITH VOLUME DEPENDING AND NON VOLUMEN DEPENING ARTERIAL HIPERTENSION TREATED HEMODIALISISMEDICUS17-11200614096366
LUTFI ZYLBEARIANAPHYLACTIC SCHOK DURING HEAMODIALISISMEDICUS1104-106200614096366
LUTFI ZYLBEARICONCETRATION OF LP IN PATIENTS WITH TERMINAL RENAL INSUFFICIENCY TREATED WITH REPATED HEMODIALISISMEDICUS725-30200714096366
LUTFI ZYLBEARIHOMOCYSTEINE NEW ARTERIOSCLEROTIC RIS FACTOR IN PATIENTS WITH TERMINAL CHRONIC RENAL INSUFFICIENCY TREATED HEMODIALISISMEDICUS731-36200714096366
LUTFI ZYLBEARILIPOPROTEIN NEW ARTERIOSCLEROTIC RISC FACTOR IN THE PATIENTS WITH TERMINAL CHRONIC RENAL INSUFFICIENCY TREATED WITH REPEATED HEMODIALISIS MEDICUS8146-1472007146-147
LUTFI ZYLBEARILIPID PROFILE AND CONCENTRATION OF APOA1 AND APO B100 IN PATIENTS WITH END STAGE RENAL DISEASE TREATED BY REPARIERED HEMODIALISIS MANUXXIX141-15220083513254
LUTFI ZYLBEARIAPOLIPOPROTEINA A-I DHE APOLIPOPROTENINA B100 FAKTORET TE RI TE REZIKUT NGA ATEROSKLEROZA E HERSHME TE PACIENTET ME IRKT TE MJEKUARA ME HEMODIALIZ PERSERITSEMEDICUSX36-42200814096366
LUTFI ZYLBEARILEVEL OF APOLIPROTEINES E IN PATIENTS WITH TERMINAL CHRONIC RENAL INSUFFOCIENCY TREATED WITH REPEATED HEMODIALISISMEDICUSXIII35-39201014096366
LUTFI ZYLBEARILIPOPROTEINA (A)FAKTORET I RI I RREZIKUT NGA ATEROSKLEROZA TE PACIENTET NE SENUNDJE E ARTERIEVE KORONAREMEDICUSSUPPL.597-9820101409-6366
LUTFI ZYLBEARIKORELAICIONI NDERMJET SEMUNDJEVE KORONARE DHE LP MEDICUSSUPP.596-9720101409-6366
LUTFI ZYLBEARIHIPERTENSIONI ARTERIAL TE PACIENTET ME IRKT MJEKIMIMEDICUSSUPP.37420081409-6366
LUTFI ZYLBEARIABNORMALITETI I LIPIDEVE DHE HIPERTENSIONI ARTERIAL TE PACIENTET ME IRKTMEDICUSSUPP.37420081409-6366
LUTFI ZYLBEARINIVELI I APOLIPOPROTEINES -E (APO-E) TEK PACIENTET ME INSUFICIENCE RENALE KRONIKE TE MJEKUAR ME HEMODIALIZE PERSERITESEMEDICUSVOL.XIII35-3920101409-6366
LUTFI ZYLBEARIHOMOCISTEINA FAKTORET E RI I PAVARUR I RREZIKUT NGA ATEROSKLEROZA TE PACIENTET ME SEMUNDJE TE ARTERIEVE KORONAREMEDICUSVOL.XIV31-3620101409-6366
LUTFI ZYLBEARILEVEL OF APOLIPOPROTEIN E IN PATIENTS WITH TERMINAL CHRONIC RENAL INSSUFFICIENCY TREATED WITH REPEATED HAEMODIALYSISMEDICUSVOL.VIII35-3920101490-6366
LUTFI ZYLBEARILIPOPROETEINA (A) FAKTORE I RI I RREZIKUT NGA ATEROSKLEROZAT E PACIENTET ME SEMUNDJE TE ARTERIEVE KORONAREMEDICUSSUPP.597-9820101409-6366
LUTFI ZYLBEARIKORELACIONI NDERMJET SEMUNDJEVE KORONAARE DHE LPMEDICUSSUPP.596-9720101409-6366
LUTFI ZYLBEARITRAJTIMI I ANEMISE RENALEMEDICUSSUPP.V253-25820101409-6366
LUTFI ZYLBEARIPOLIMORFIZMI I APO-E TE PACIENTET ME IRKT TE TRAJTUAR ME HDMEDICUSSUPP.V97-9820101409-6366
LUTFI ZYLBEARIROLI I PROTEINES -CREAKTIVE TE PACIENTET ME INSUFICIENCA RENAL KRONIKE NE FAZEN TERMINALE DHE GJATE TRAJTIMIT ME HEMODIALIZEMEDICUSVPL.XV20111409-6366
LUTFI ZYLBEARIROLI I TROPONINES-I KARDIAKE NE ZHVILLIM E SEMUNDJEVE KARDIOVASKULARE TE PACIENTET ME IRKT TE TRAJTUAR ME HEMODIALIZE MEDICUSVOL.6284-29320111409-6366
LUTFI ZYLBEARINDRYSHIMET E LIPO/APOPRTOTEINAVE DHE ROLI I STATINEVE TE PECIENTET E MJEKUAR ME HEMODIALIZEMEDICUSVOL.6284-29320111409-6366
LUTFI ZYLBEARI2 D STRAIN NE INFRAKTIN AKUT TE MIOKARDITMEDICUSVOL.XVI21-2720111409-6366
LUTFI ZYLBEARIEHOKARDIOGRAFIA DEMTIMET E HERSHME TE MIOKARDIT NE TE SMEURET DIABETIK JO SIMPTOMATIKMEDICUSVOL.XVI21-2720111409-6366
LUTFI ZYLBEARIFAKTORI PSIQIK DHE GJENDJA SOCIA-EKONOMIKE SI RISK FAKTOR PER SINDROMIN AKUT KORONAR TEK POPULLATAE TETOVES ME RRETHINEMEDICUSVOL.XVI28-3020111409-6366
LUTFI ZYLBEARIMETODAT E REJA ECHOKARDIOGRAFIKE NE PERCAKTIMIN E PAMJAFTUESHMERISE SE ZEMRES TE BAZUARA NE 3D SPECKLE TRANCKING TEKNOLOGJINE.PAMJAFTUESHMERIA SISTELOKE (SHF)DHE AJP DIASTOLOKE E ZEMRES DALLIMET E TYRE.MEDIKUSVOL.XVIII2020111409-6366
LUTFI ZYLBEARICHANGES OF LIPOPROTEINS AND THE ROLE OS STATIN OF PATIENTS WITH TERMINAL CHRONIC RENAL INSUFFICIENCY TRWATED WITH REPEATED HEMODIALYSISINTERNATIONAL JOURNAL OF SCIENTIFIC AND ENGIEERING RESEARCHVOL.32012I014334
LUTFI ZYLBEARIMANIFESTIMET E PERIKARDITIT NE FAZEN E FUNDIT TE DEMTIMIN TE VESHKAVE DHE PACIENTET E TRAJTUAR ME HEMODILIZEMEDICUSVOL.XVII20121409-6366
LUTFI ZYLBEARIEFEKTET POZITIVE TE TORVEX-IT (ATORVASTATINIT)NE TRAJTIMIN E HIPERKOLESTEREMISE DHE HIPERTRIGLICEREDEMISE SE HERSHME MEDICUS2013
LUTFI ZYLBEARIATEROSKLEROZA AKCELERUESE DHE NDIKIMI I ABNORMALITETEVE TE LIPOAPOPROTEINAVE NE PARAQITJEN E MANIFESTIMEVE VASKULARE ME KALCIFIKATE TE PACIENTET UREMIKEMEDICUSVOL.1875-842013140-6366
LUTFI ZYLBEARICONCENTRATION OF APOLIPOPROTEIN -B100 (APO-B100)AND LIPOPROTEIN ALP A AT PATIENTS WITH DIABETS MELLITUS AND HEMODIALYSISINTERNATIONAL JOURNAL OF SCIENTIFIC AND ENGINEERING RESARCHVOL.52014I054636
LUTFI ZYLBEARITHE CARDIAC-TROPONIN-I(TN-I)AND ITS ROLE IN THE CARDIOVASKULAR DISEASE RECOVERY OF UREMIC PTIENTS TREATED WITH REPEATED HEMODYALISISINTERNATIONAL JOURNAL OF SCIENTIFIC AND ENGINEERING HENODYALISISVOL.52014I014334
LUTFI ZYLBEARIMETABOLISM OF APOLIPOPROTEIN C-III (APO-C-III)IN UREMIC PATIENTS TREATED WITH CHRONICAL HEMODIALYSISINTERNATIONAL JOURNAL OF SCIENTIFIC AND ENGINEERING RESEARCH52014
LUTFI ZYLBEARIIMPACT OF HYPERTENSION AND LIPIDS IN THE PROGRESION OF CHRONIC RENAL DISEASEINTERNATIONAL JOURNAL OF SCIENTIFIC AND ENGINEERINGVOL.52014
LUTFI ZYLBEARITHE EFFECT OF INHIBITORS OF HMG-COAREDUCATASAE AND CONCENTRATION OF TOTAL CHOLESTEROL,LOW-DENSITY CHOLESTEROL,HIGH-DENSITY CHOLESTEROL AND TRIGLOCERIDES IN PATIENTS WITH END-STAGE-RENAL DISEASE TREATED WITH REPEATED CHRONICAL HAEMODYALISIS INTERNATIONAL JOURNAL OF EDUCATION SCIENCE TECHNOLOGYVOL.0120151857-9450
LUTFI ZYLBEARIDYSLIPIDEMIA IMPACT IN PRESENTATION OF CARDIOVASKULAR DISEASE OF PATIENTS WITH DIEBETES MELITUS TRETMENT OF DYSLIPI8DEMIAINTERNATIONAL JOURNAL OS SCIENTIFIC AND ENGINEERING REASERCHVOL.52015
LUTFI ZYLBEARITHE IMPACT OF DIABETES ON THE RATE OF PROGRESS OF CHRONIC RENAL FAILUREINTERNATIONAL JOURNAL OF SCIENTIFIC AND ENGINEERING RESEARCHVOL.620152229-5518
LUTFI ZYLBEARILIPOPROTEIN LIPASE ACTIVITY AND DISLIPIDEMIA IN UREMIC PATIENTS TREATED WITH HEMODYALISISINTERNATIONL JOURNAL OF SCIENTIFIC AND ENGINEERING RESEARCHVOL.620152229-5518
LUTFI ZYLBEARICORELATION BETWEEN HYPERHOMOCYSTENEMIA AND CARDIOVASKULAR DISEASE IN PATIENTS WITH CHRONIC TERMINAL RENAL FAILUREINTERNATIONAL JOURNAL OF SCIENTIFIC AND ENGINEERING RESEARCH VOL.620152229-5518
LUTFI ZYLBEARIHYPERHOMOCYSTEINEMIA AND LIPIDS ON THE ONSET ESSENTIAL ARTERIAL HYPERTENSION AND CORONARY DISEASE FAILUREINTERNATIONAL JOURNAL OF SCIENTIFIC AND ENGINERING RESEARCHVOL.620152229-5518
LUTFI ZYLBEARIIMPACT OF APOLIPOPTOTEIN B100 AND APOLIPOPROTEIN-A1 THE APERANCE OF EARLY ATHEROSCLEROSIS IN UREMIC PATIENTS TREATED WITH BICARBONATE HEMODYALISYSINTERNATIONAL JOURNAL OF SCIENTIFIC AND ENGINEERING RESEARCH VOL.620152229-5518
LUTFI ZYLBEARIUREMIC DISLIPIDEMI IN PATIENTS WITH ESRD TREATED WITH INTERMITENT CHRONICAL HEMODIALYSISINTERNATIONAL JOURNAL OF ADVANCE RESERCHVOL.420152320-9194
LUTFI ZYLBEARIDYSLIPIDEMIA IN UREMIC PATIENTS THREATED WITH INTERMITENT DIALYSISINTERNATIONAL JOURNAL OF SCIENTIFIC AND ENGINEERING RESEARCHVOL.620152229-5518
LUTFI ZYLBEARIMETABOLISM OF LIPOPROTEIN LIPASAE PATIENTS WITH ESRD TRETAED WITH HEMODYALISISINTERNATIONAL JOURNAL OF ADVANCE RESEARCH VOL.320152320-9194
LUTFI ZYLBEARIMETABOLISM DISTURBANCE APOLIPOPROTEIN-E IN PATIENNTS WITH ESRDINTERNATIONAL JOURNAL OF ADVANCES RESERCH VOL.420162320-9194
LUTFI ZYLBEARIAPOLIPOPROTEIN E-POLYMORPHOSIS AT UREMIC PATENTSWITH HEMODYALISISINTERNATIONAL JOURNAL OF SCIENTIFIC AN ENERGEERING RESEARCH VOL720160931-0509
LUTFI ZYLBEARIMETABOLISM DISTURBANCE APOLIPOPROTEIN-E IN PATIENTS WITH ESRDINTERNATIONAL JOURNAL OF SCIENTIFIC AND ENGINEERING RESEARCHVOL.720162229-5518
LUTFI ZYLBEARICHRONIC KIDNEY DIDEASE IN DIABETESINTERNATIONAL JOURNAL OF ADVANCE RESEACHVOL.720162229-5518
LUTFI ZYLBEARIEOSINOPHIL CATIONIC PROTEIN IN UREMIC DIALYZED PATIENTS WITH INTRACTABLE PRURISTISIJERSVOL.72016
SADI BEXHET NEXHBEDIN KAHRIMANI BASRI LENJANI DORONTINA BEXHETIMENAXHIMI I ARITMIS TE PACIENTET UREMIK TE TRAJTUAR ME HEMODIALIZ KRONIKEASEM11-122016
DRITON SELMANI GAZMEND ZYLBEARI ZAMIRA BEXHETI METABOLIZM OF APOLIOPROTEIN C-II(APO C -II)IN UREMC PATIENTS TREATED WITH CHRONICAL HEMODIALISIS IJERS720165.237
LUTFI ZYLBEARIGLUTATHIONE TRANSFERASES AS A MARKERS OF TUBULAR CELLS DYSFUNCTION IN ACUT RENAL FAILURE PATIENTS.INTERNATIONAL JOURNAL OF ADVANCE RESEARCH VOL.720162229-5518
LUTFI ZYLBEARIANTIOXIDANT STATUS IN HEMODIALYSIS PATIENTS INTERNATIONAL JOURNAL OD ADVANCE RESEARCHVOL.720162229-5518
LUTFI ZYLBEARIDISTURBANCE OF APOLIPOPROTEIN IN UREMIC PATIENTS TRATED WITH DYALISISINTERNATIONAL JOURNAL OF ADVANCE RESEARCHVOL.720162229-5518
LUTFI ZYLBEARIANEMIA MENAGMENT IN UREMIC PATIENTS TEREATED WITH CHRONIC INTERMITENT DIALYSISINTERNATIONAL JOURNAL OF ADVANCE RESEARCHVOL.720162229-5518
LUTFI ZYLBEARIEFFECTS OF PHYSICAL EXERCISE ON HYPERLIPIDEMIA INTERNATIONAL JOURNAL OF ADVANCE RESEARCHVOL720162229-5518
LUTFI ZYLBEARIRHABDOMYOLYSIS AND ACUTE KIDNEY INJURIINTERNATIONAL JOURNAL OF ADVANCE RESEARCHVOL.720162229-5518
LUTFI ZYLBEARIBLOOD CONCENTRATION OF IMUNOREACTIVE C PEPTIDE OF PARATHORMON C-IPTH AND CALCITONIN AND CORRELATION BETWEEN THE NUMBER AND MAGNITUDE OF HAWSHIP LACUNES IN PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE TRESTED AND NON-TREATED WITH REGULAR HAEMODYALISISIINTERNATIONAL JOURNAL OF ADVANCES RESEARCHVOL.720162229-5518
LUTFI ZYLBEARICONCENTRATION OF LIPOPROTEININTERNATIONAL JOURNAL OF ADVANCE RESEARCHVOL72016229-5518
LUTFI ZYLBEARIAPOLIPOPRTOTEINS-E IN PATIENTS WITH END STAGE RENAL DISEASE TREATED WITH REPEATED HEMODIALYSISINTERNATIONAL JOURNAL OF ADVANCES RESERACH VOL.720162229-5518
LUTFI ZYLBEARIANAEMIA IN PATIENTS WITH END STAGE RENALE DISEASEINTERNATIONAL JOURNAL OF ADVANCES RESEARCHVOL.720162229-5518
LUTFI ZYLBEARIIMPACT DYSLIPIDEMIA AND TRETAMENT OF PATIENTS WITH DIABETES MELITUS AND CARDIOVASKULAR DISEASESINTERNATIONAL JOURNAL OD ADVANCE RESEARCHVOL.720162229-5518
LUTFI ZYLBEARIDISTURBANCE OF LIPOPROTEIN LIPASEAE IN PATIENTS WITH GLOMERULONEOHRITID CHRONICAINTERNATIONAL JOURNAL OF SCIENTIFIC AND ENGINEERIN RESEARCHVOL720162229-5518
LUTFI ZYLBEARIDIABETES MELITUS AND DYSLIPIDEMIA IN UREMIC PATIENTS TREATMENTINTERNATIONAL JOURNAL OF SCIENTIFIC AND ENGINEERING REASERCHVOL.720162229-5518
LUTFI ZYLBEARILIPOPROTEIN LIPASEAE AND DISTURBANCE IN PATIENTS WITH GLOMERULONEPHRITIS CHRONICAINTERNATIONAL JOURNAL OF ADVANCMENTS IN RESEARCH AND TECHNOLOGY20162278-7763
LUTFI ZYLBEARIHIGHT PRESSURE AND CHRONIC RENAL DISEASEINTERNATIONAL JOURNAL OF SCIENTIFIC AND ENGINEERING RESEARCHVOL720162229-5518
LUTFI ZYLBEARIBENEFITS OF TYPE MEMBARNE HIGHT-FLUX AND LOW MEMBRANE INEFYCACY OF HEMODIALYSIS IN PATIENTS WITH ESRDINTERNATIONAL JOURAL OF SCIENTIFIC AND ENGIENNERING RESERACVOL.720162229-5518
LUTFI ZYLBEARITREATMENT AND DYSLIPIDEMIA OF PATIENTS WITH DIABETES MELLITUS AND CARDIOVASKULAR DISEASSEINTERNATIONAL JOURNAL OS SCIENTIFIC AND ENGINEERING RESEARCHVOL.720162229-5518
LUTFI ZYLBEARITREATMENT OF ANAEMIA IN UREMIC PATIENTS WITH EPO THERAPY INTERNATIONAL OF JOURNAL SOFWARE RESEARCH VOL.42016229-5518
LUFI ZYLBEARINDIKIMI I HIPERTENSIONIT ARTERIAL NE PROGRESN E SEMUNDEJVE KORONAREINTERNATIONAL JOURNAL OF MEDICAL SCIENCE
LUTFI ZYLBEARICALCITROL AND ANAEMIA IN HEMODIALYSISINTERNATIONAL JOURNAL OF MEDICAL SCIENCES20162229-5518
LUTFI ZYLBEARIMETABOLISM OF APOLIPOPROTEINS -E IN UREMIC PATIENTS TREATED WITH LONG TERM HEMODIALYSISINTERNATIONAL JOURNAL OF SCIENTIFIC AND ENGINEERING RESEARCH20162229-5518
LUTFI ZYLBEARIIMPACT DYSLIPIDEMIA AND TREATMENT OF PATIENTS WITH DIABETES MELITUS AND CARDIOVASKULAR DISEASESINTERNATIONAL JOURNAL OF SCIENTIFIC ENGINERING REASERCH20162229-5518
LUTFI ZYLBEARITHE IMPORTANCE OF METHODOLOGY OFCREATING REFERENCES PRICES OF DRUGSINTERNATIONAL JOURNAL OF SCIENTIFIC ENGINERING20162229-5518
LUTFI ZYLBEARIEFFECTS OF PHYSICAL EXERCISE OF DYSLIPIDEMIAINTERNATIONAL JOURNAL OF SCIENTIFIC ENGINEERING RESERACH20172229-5518
LUTFI ZYLBEARIPLEURAL EFFUSION IN PATIENTS TREATED WITH LONG TERM HEMODIALYSISINTERNATIONLA JOURNAL OF SCIENTIFIC AND ENGINERRING RESEARCH20172229-5518
LUTFI ZYLBEARILEVEL OF APOLIPOPROTEINS E-PATIENTS WITH TERMINAL CHRONIC RENAL INSSUFFICIENCY TREATED WITH REPEATED HAEMODIALYSIS MEDICUS XIII35-392010
Authors
Title
Conference Name
Place
ISBN
Year
LUTFI ZYLBEARIEFFECT OF UREMIC DYSLIPIDEMIA IN UREMIC PATIENTS AND DIABETES MELLITUS-TREATED WITH MEDICATION THERAPY53 INTERNATIONAL CONGRESS ERA-EDTA
LUTFI ZYLBEARICARDIOVASKULAR DISEASE AND TROPONIN-I IN UREMIC PATIENTS THREATED WITH HAEMODYALISISINTERNATIONAL CONGRES ERA-EDTA
LUTFI ZYLBEARITRETAMENT OF LIPIDS IN PATIENTS WITH RHEUMATOID ARTHRITISINTERNATIONAL CONGRESS OF NATURAL AND ENGINERING SCIENCES
LUTFI ZYLBEARIMANAGING OF DYSLIPIDEMIA IN PATIENTS WITH END STAGE RENAL DISEASE TREATED WITH HEMODIALYSISINTERNATIONAL CONGRESS ON NATURAL AND ENGINERING SCIENCES
LUTFI ZYLBEARILOW MOLECULAR WEIGHT HEPARINS IN THE TRATEMEN OF RECURENT IVF-ET FAILUREINTERNATIONAL CONGRESS ON NATURAL AND ENGINEERING SCIENCES
LUTFI ZYLBEARICORRELATION BETWEEN HYPOALBUMINEMIA AND HYPERCOAGULABLE STATE DURING PREGNANCYINTERNATIONAL CONGRESS ON ANTURAL AND ENGINERING SCIENCES
LUTFI ZYLBEARIAPOLIPOPROTEIN -E AND CHRONIC RENAL DISEASEINTERNATIONAL CONGRESS ON NATURAL AND ENGINEERING SCIENCES
LUTFI ZYLBEARIEFFECT OF ARTERIAL HYPERTENSION IN PROGRESS IN END STAGE RENAL DISEASEINTERNATIONAL CONGRESS ON NATURAL AND ENGINERING SCIENCES
LUTFI ZYLBEARITREATMENT OF ARTERIAL HYPERTENSION INTERNATIONAL CONGESS OF NATURAL AND ENGINEERING SCIENCES
LUTFI ZYLBEARIHYPOURICEMIA IS RISK FACTOR FOR HEMODIALYSIS PATIENTS INTERNATIONAL CONGRESS ON NATURAL AND ENGINEERING SCIENCES
LUTFI ZYLBEARIASSESSMENT OF MEDICAL FACTORS THAT AFFWCT ARTERIAL HYPERTENSION CONSEQUENCE OF HYPERCHOMOCYSTENIAMTHIRD INTERNATIONAL MEDICAL CONFERENCE IN SPECIALITES
LUTFI ZYLBEARITHE INCREASING TENDENCY OF INCIDENT ESRD PATIENTS IN POLOG REGION SECOND MEETING OF THE NATIONAL SOCIETIES OF NEFROLOGY FROM MACEEONIA,ALBANIA AND KOSOVOSTRUGA
LUTFI ZYLBEARIPREVENCA E PROGRESIONIT TE SEMUNDJEVE KRONIKE TE VESHKEVE NE PRAKTIKEN PRIMARE DHE SEKONDARESIMPOZIUM DITA BOTERORE E VESHKEVETETOVE2011
LUTFI ZYLBEARIMENAXHIMI PSIKIATRIK I CREGULLIMEVE TE PANIKUT NE REPARTIN PSIKIATRIK TE TETOVE4 INTERNATIONAL EMERGENCY MEDICINE CONFERENCE
LUTFI ZYLBEARIMJEKIMI I KRIZES HIPERTENSIVE TE PACIENTET ME HEMODIALIZE NDERMJET SEANCAVE TE HEMODIALIZES4 INTERNATIONAL EMERGENCY MEDICINE CONFERENCE PRISHTINE
Authors
Title
Publisher
Year
ISBN
LUTFI ZYLBEARI SEMUNDJET E VESHKAVEARBERIA DESIGN2016616.61(035)
LUTFI ZYLBEARINDIHMA E PAREMJEKESIA2016978-608-66165-4-0
LUTFI ZYLBEARIKUJDESI SHENDETESOR MJEKESIA2016978-608-66165-4
LUTFI ZYLBEARIETIKA DHE DEONTOLOGJIAMJEKESIA2015978-608-66165-7-1
LUTFI ZYLBEARIEKZAMINIM KLINIK IMJEKESIA2015978-608-4800-15-6
LUTFI ZYLBEARIEKZAMINIM KLINIK IIMJEKESIA2015978-608-4800-15-6
LUTFI ZYLBEARIPOLICISTOZA AUTOSOMALE E VESHKAVEFIGA - TETOVE2017978-608-4800-32-3
LUTFI ZYLBEARIDESHTIMI KRONIK PERFUNDIMTARI VESHKAVEMJEKESIA2017978-608-66165-0-2
LUTFI ZYLBEARIHIPRTENSIONI ARTERIAL - MJEKIMIMJEKESIA2017 978-608-66165-9-8
LUTFI ZYLBEARINEFROPATITE HEREDITARE TE BASHKELINDURAMJEKESIA2018978-608-66165-02-6
LUTFI ZYLBEARIDESHTIMI AKUT I VESHKAVEMJEKESIA2017978-608-66165-1-9
LUTFI ZYLBEARIPROFILI I DISLIPIDEMISE DHE ABERACIONET E APOLIPOPROTEINEVE TE PACIENTET E MJEKUAR ME HEMODIALIZE E PERSERITESEMJEKESIA2018978-608-66165-9-5
LUTFI ZYLBEARIMJEKESIA EMERGJENTEMJEKESIA2017978-608-66161-0-6
LUTFI ZYLBEARIPARANDALIMI I INFEKSIONEVE NOSOKOMIALEMJEKESIA2016978-608-4800-16-3
LUTFI ZYLBEARIANESTEZIONI DHE REANIMCIONIMJEKESIA2017978-608-66161-1-3

View publications by citation.

Publications, in process.